Patricia M Desmond Selected Research

Patricia M Desmond Research Topics

Disease

28	Stroke (Strokes) 01/2023 - 07/2002
24	Ischemic Stroke 01/2023 - 09/2003
12	Infarction (Infarctions) 01/2022 - 07/2002
8	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2014
4	Hematoma 01/2022 - 11/2013
3	Dementia (Dementias) 01/2023 - 04/2014
3	Temporal Lobe Epilepsy 01/2022 - 12/2020
3	Cognitive Dysfunction 01/2021 - 04/2014
3	Hemorrhage 01/2021 - 11/2013
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 10/2012
3	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2018 - 01/2014
3	Lacunar Stroke 07/2016 - 06/2013
2	Thrombosis (Thrombus) 01/2023 - 01/2018
2	Brain Edema (Cerebral Edema) 01/2022 - 11/2021
2	Idiopathic Generalized Epilepsy 01/2022 - 12/2020
2	Epilepsy (Aura) 12/2020 - 10/2020
2	Atrophy 01/2020 - 01/2016
2	Cerebral Infarction 01/2020 - 01/2018
2	Cerebral Hemorrhage 01/2019 - 01/2014
2	Body Weight (Weight, Body) 01/2018 - 03/2015
2	Hyperglycemia 09/2003 - 07/2002
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Hippocampal Sclerosis 01/2022
1	Edema (Dropsy) 01/2022
1	Generalized Epilepsy 01/2022
1	Flushing 01/2021
1	Nephrogenic Fibrosing Dermopathy 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2020
1	Epileptic Syndromes 01/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2019
1	Disease Progression 03/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2016
1	Retrograde Degeneration 01/2016
1	Vascular Diseases (Vascular Disease) 12/2014
1	Transverse Myelitis (Necrotizing Myelitis) 12/2014
1	Kidney Diseases (Kidney Disease) 06/2013
1	Diabetes Mellitus 08/2004
1	Ischemia 08/2004

Drug/Important Bio-Agent (IBA)

22	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 04/2008
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2004
10	Tenecteplase FDA Link 01/2023 - 01/2018
6	Amyloid (Amyloid Fibrils)IBA 01/2021 - 10/2012
5	Cytidine Triphosphate (CTP)IBA 07/2016 - 12/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 09/2003
3	Blood Glucose (Blood Sugar)IBA 08/2004 - 07/2002
2	Immunoglobulin E (IgE)IBA 01/2022 - 12/2020
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022 - 01/2022
2	GadoliniumIBA 01/2022 - 01/2021
2	Glutamic Acid (Glutamate)FDA Link 12/2020 - 01/2020
2	Glutathione (Reduced Glutathione)IBA 12/2020 - 01/2020
2	Apolipoproteins E (ApoE)IBA 10/2015 - 04/2014
1	Amyloid beta-PeptidesIBA 01/2023
1	Waste Products (Waste Product)IBA 01/2021
1	Aminobutyrates (Aminobutyric Acid)IBA 12/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2020
1	Butyric Acid (Butanoic Acid)IBA 01/2020
1	Inositol (Myoinositol)IBA 01/2016
1	CreatineIBA 01/2016
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2016
1	CollagenIBA 12/2014
1	HemosiderinIBA 01/2014
1	Aligeron (AS 2)IBA 06/2013
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 08/2004
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2002

Therapy/Procedure

16	Therapeutics 01/2023 - 12/2011
6	Thrombectomy 01/2020 - 03/2015
2	Contraindications 01/2020 - 01/2018
2	Catheters 01/2020 - 01/2018
1	Punctures 01/2022
1	Intravenous Infusions 01/2018
1	Craniotomy 03/2016
1	Surgical Decompression 01/2016
1	Aftercare (After-Treatment) 06/2015
1	Stents 03/2015
1	Immunotherapy 01/2014
1	Secondary Prevention 11/2002
1	Glycemic Control 07/2002